Article Details
Retrieved on: 2021-01-12 19:07:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Health Canada approves Lundbeck's (Pr)VYEPTI® (eptinezumab)--the first and only intravenous preventive treatment for migraine. Lundbeck Canada ...
Article found on: www.newswire.ca
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here